
Biotangents
Develops pen-side diagnostic devices to detect infectious diseases in livestock quickly and to build complex genetic constructs from multiple DNA parts.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 Valuation: €0.0 | round | |
* | £2.3m | Early VC | |
Total Funding | 000k |
Related Content
Biotangents is a company specializing in the development of veterinary diagnostic tests aimed at detecting infectious diseases in livestock. Operating primarily in the agricultural and veterinary sectors, Biotangents serves veterinarians and farmers who require quick and accurate diagnostic solutions to manage animal health. The company leverages its proprietary isothermal amplification technology, Moduleic, to simplify diagnostic protocols, miniaturize equipment, and deliver point-of-care diagnostics. This technology enables the identification of diseases such as bovine viral diarrhoea (BVD), mastitis, bovine respiratory disease (BRD), and brucellosis within a day, and potentially within an hour. By providing rapid and actionable results, Biotangents helps farmers isolate infected animals promptly, thereby preventing the spread of diseases and minimizing economic losses. The business model revolves around selling diagnostic kits and tools directly to veterinary clinics and agricultural enterprises. Revenue is generated through the sale of these diagnostic products and potentially through service agreements for ongoing support and updates.
Keywords: veterinary diagnostics, livestock health, molecular technology, isothermal amplification, point-of-care, BVD, mastitis, BRD, brucellosis, rapid detection.